IMPORTANCE Fine particulate matter (smaller than 2.5 μm) (PM 2.5 ) air pollution is a major global risk factor for cardiovascular (CV) morbidity and mortality. Few studies have tested the benefits of portable air filtration systems in urban settings in the United States.
T he World Health Organization attributes more than 4 million deaths per year to ambient fine (<2.5 μm in diameter) particulate matter (PM 2.5 ).
1 Short-term exposures (eg, days) increase risks for numerous cardiovascular (CV) events, including myocardial infarction, stroke, and heart failure. 2 Longer-term exposures (eg, years) amplify this risk and potentiate development of chronic cardiometabolic conditions (eg, type 2 diabetes, hypertension).
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The extremely high air pollution levels across Asia are a major public health threat. 1 However, mounting evidence indicates that even low levels of PM 2.5 exposure within World Health Organization air quality guidelines of less than 10 μg/m 3 pose significant health risks. 1, 3 Despite improvements in air quality during prior decades, the range of PM 2.5 concentrations across the United States remains associated with excess mortality. 3 As such, Brook et al 4 and Giles et al 5 have advocated more testing of preventive strategies that individuals can use to protect their health.
With the US population spending nearly 90% of their time indoors-70% of this in their own residence 6,7 -portable residential air filtration units may be a practical tool for reducing PM 2.5 exposures. A growing body of studies shows that highefficiency particulate arrestance (HEPA) filtration can reduce indoor PM 2.5 concentrations and may deliver health benefits. Although some trials demonstrated improvements in surrogate CV outcomes, including vascular function and blood pressure (BP), [8] [9] [10] [11] overall evidence remains mixed. [12] [13] [14] Few studies have been performed in the United States with pollution levels more representative of urban environments faced by millions of at-risk individuals. In addition, a paucity of data exists among the elderly, the fastest growing vulnerable population, who are particularly susceptible to adverse health effects of PM 2.5 exposure. [15] [16] [17] [18] [19] In this context, we tested the capacity of 2 inexpensive, commercially available air filtration systems to reduce PM 2.5 exposures among elderly adults in a low-income senior residence in a typical urban US environment (Detroit, Michigan). We hypothesized that air filtration would reduce personal PM 2.5 exposure, which differs from indoor levels due to several factors, including daily activities, 20 thereby yielding improvements in CV health. Change in BP was selected as the primary end point because high BP is the leading cause of global morbidity and mortality 1, 21 and because PM 2.5 exposure has been shown to increase BP in our study location [22] [23] [24] and across global environments.
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Methods
Study Population
The Reducing Air Pollution in Detroit Intervention Study (RAPIDS) enrolled 40 nonsmoking adults not receiving supplementary oxygen and living in a government-subsidized, lowincome residential building for senior citizens in Midtown Detroit; participants received an in-residence air filtration intervention. The building is near a major state highway (approximately 100 m, with 21 900 vehicles/d), 27 ) and hydronic baseboard heating. Participants were not restricted from going outdoors or opening windows during the interventions. The study protocol is found in Supplement 1. The study was approved by the institutional review board of the University of Michigan, and participants signed a written informed consent document during screening visits.
Intervention Study Design
RAPIDS was a randomized, double-blind, 3-way crossover intervention study conducted from October 21, 2014, through November 4, 2016 (excluding December 1 through April 30). Interventions included 3 blinded scenarios in computergenerated random order: unfiltered ambient air exposure (sham filtration), low-efficiency (LE) HEPA-type filtration, and high-efficiency (HE) true-HEPA filtration of ambient air using air purifier systems in the bedroom and main living space of each residence. The LE filter removes 99% of particles at 2.0 μm in size, whereas the HE filter removes 99.97% of particles at 0.3 μm in size. Each scenario lasted 3 days, separated by 1-week washout periods.
On Monday during each study week, an unblinded team member placed randomized portable air filter systems (HAP424-U; Holmes), with a clean air delivery rate of 3.29 m 3 / min for smoke, in each participant's residence. Participants, health technicians, and the data analysists (S.D.A. and J.D.) were blinded to intervention ordering. Participants wore personal air monitors starting at 8:00 AM and carried them for 72 hours. Each participant underwent CV outcome testing in a fasting condition (>8 hours) at the same time between 8:00 and 10:00 AM on 3 consecutive days starting 24 hours after filter system placement (Tuesday through Thursday). Daily PM filter samples were collected in each participant's residence throughout each 3-day filtration period, during which time no filtration, LE recirculating filtration (HAPF30D-U2 HEPAtype filter; Holmes), or HE recirculating filtration (HAPF300D-U2 true-HEPA filter; Holmes) was used. For the sham condition, the air filtration systems (ie, HAP424-U) were operated without any filter element. specifically powered the trial based on a change in SBP because in prior studies in Detroit 22,23 that had been completed at the time of designing this study, ambient PM 2.5 had shown stronger and more consistent association with SBP compared with DBP. A repeated-measures design with 40 participants provided 90% power to detect a 1.4-mm Hg difference in SBP between active filtration interventions (HE and LE together) vs sham filtration. Secondary outcomes included noninvasive aortic hemodynamics, pulse-wave velocity (PWV), and heart rate variability (HRV). First, participants rested while seated for 5 minutes, and then CV outcome measurements were performed each morning in the following order: BP (approximately 5 minutes), PWV (approximately 10 minutes), and HRV (approximately 6 minutes). The measurement protocol is detailed in Supplement 1 and briefly reviewed below.
Brachial BP Five-minute resting seated BP, a well-established causal factor for CV events, 21 was measured according to guidelines 28 using an automatic validated device (BpTRU; http://www .medsource-sw.com/blood-pressure/item-bpm-100/). The mean of the last 5 of 6 automated BP measurements (taken at 60-second intervals) was recorded.
Central Aortic Hemodynamics and PWV
A detection system (SphygmoCor System; http://atcormedical .com) was used to measure aortic augmentation pressure and augmentation indices (alone and controlled to a heart rate of 75 beats/min), metrics of aortic arterial pressure-wave reflection, and aortic systolic and pulse pressure. Carotid-femoral PWV was also determined by applanation tonometry using this system.
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Cardiac Autonomic Function Participants rested supine for 6 minutes of continuous electrocardiographic monitoring (Evo Holter system; Spacelabs Healthcare). Time domain (SD of normal-to-normal R-R intervals) and frequency domain (high and low frequencies) HRV metrics were analyzed using echocardiographic analysis software (Pathfinder system; https://www.spacelabshealthcare .com:443/).
Exposure Assessment
Indoor Air Sampling Indoor PM 2.5 samples were collected in the living room at the furthest point from the air filtration unit. Twenty-four-hour indoor PM 2.5 samples were collected daily on polytetrafluoroethylene (PTFE [Teflon; Pall Laboratory]) filters using cyclone sample inlets at a flow rate of 16.7 L/min.
Personal Air Sampling
Each participant wore a battery-powered personal particulate monitor (pDR-1500; Thermo Scientific) that collected particles on 37-mm PTFE filters for subsequent gravimetric analysis. The monitor also continuously recorded PM 2.5 concentration, relative humidity, and temperature. Participants were instructed to place monitors on a nearby nightstand or equivalent while sleeping.
Outdoor Air Sampling
We collected 24-hour ambient PM 2.5 samples daily on PTFE filters using a dichotomous sequential air sampler (PartisolPlus Model 2025, Rupprecht and Patashnick, Inc). All samples were processed and analyzed in class 100 ultraclean rooms at the Michigan State University Exposure Science Laboratory and the University of Michigan Air Quality Laboratory.
Statistical Analysis
Summary statistics were calculated as the overall mean (SD) of the mean value for each participant under each intervention scenario. We tested whether LE and HE filtration resulted in CV outcomes statistically better than sham filtration using mixed models of the following formula:
where CV it is the continuous CV health outcome in individual i at time t; b o is the overall intercept; β 11 and β 12 are the overall effects of LE vs unfiltered air and HE vs unfiltered air, respectively; CONFOUNDER it is a vector of time-varying covariates that may confound associations of interest (eg, intervention sequence, calendar time, month of intervention, temperature, or day of intervention); and β 2 is the associated effect of these confounders. As a balanced design in which every participant contributes information to every intervention, timeinvariant characteristics such as sex, race, and age cannot confound the associations of interest. Within the error term of this model (ε it ), we accounted for the repeated nature of the samples from each participant and allowed for increased correlation among observations from the same participant that are closer in time.
In sensitivity analyses, we explored the inclusion of additional adjustment for outdoor PM 2.5 exposure, examined different covariance structures, and tested whether intervention effects varied during the 3 days of sampling or by personal characteristics (ie, obesity, defined as body mass index [calculated as weight in kilograms divided by height in meters squared] ≥30, and sex) using interaction terms in our models. We also tested the effects of any filtration vs no filtration. We used SAS software (version 9.3; SAS Institute Inc) to implement these models; P < .05 indicates significance. Figure 1 ). Less complete information was available on the secondary outcomes, leaving 34 participants and 208 measurements for secondary analyses. (Figure 2A) . Figure 2B illustrates the temporal variation of brachial SBP and DBP during the interventions and shows that LE filtration reduced mean SBP by 3.4 mm Hg (95% CI, −6.8 to −0.1 mm Hg) and mean DBP by 2.2 mm Hg (95% CI, −4.2 to −0.3 mm Hg). High-efficiency filtration decreased mean SBP by 2.9 mm Hg (95% CI, −6.2 to 0.5 mm Hg) and mean DBP by 0.8 mm Hg (95% CI, −2.8 to 1.2 mm Hg), respectively. These reductions did not differ significantly between HE and LE air filtration (P = .75 for SBP and P = .14 for DBP).
Results
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In post hoc exploratory analyses, we evaluated for potential effect modifiers of the BP responses. The 19 individuals with obesity experienced significantly greater decreases in SBP (−7.5 mm Hg; 95% CI, −12.0 to −3.1 mm Hg) and DBP (−2.9 mm Hg; 95% CI, −5.6 to −0.2 mm Hg) with filtration compared with the 21 nonobese participants (SBP, −0.4 mm Hg [95% CI, −3.7 to 4.5 mm Hg]; DBP, −0.6 mm Hg [95% CI, −3.1 to 2.0 mm Hg]) (P < .001 for interaction for brachial SBP; P = .01 for interaction for brachial DBP) ( Figure 2C ). Except for PWV, HE and LE filtration also improved all secondary outcomes more for obese participants than for nonobese participants, although these differences only met statistical significance for aortic pulse pressure (decrease by 4.6 mm Hg; 95% CI, −7.3 to −1.8 mm Hg). The intervention effects did not consistently differ by other factors, including sex and day of intervention.
Among secondary CV study outcomes, central aortic, aortic augmentation pressure, pulse pressure, and augmenta- Abbreviations: AIx@75, augmentation index controlled to a heart rate of 75 beats/min; DBP, diastolic blood pressure; HE, high-efficiency; HF, high frequency; HRV, heart rate variability; LE, low-efficiency; LF, low frequency; PM 2.5, fine (<2.5 μm) particulate matter; PWV, pulse-wave velocity; SBP, systolic blood pressure; SDNN, SD of normal-to-normal R-R intervals.
a Mean (SD) values were estimated using the mean value for each participant within each scenario. tion index controlled to a heart rate of 75 beats/min tended to decrease during the filtration interventions. For instance, compared with no filtration, any filtration reduced pulse pressure by 1.9 mm Hg (95% CI, −3.7 to −0.01 mm Hg), but remaining secondary outcomes were not statistically different from no association ( Figure 3) . No significant consistent differences between interventions were observed for PWV and cardiac HRV variables (eTable in Supplement 2).
Discussion
Fine particulate matter air pollution is the fifth leading risk factor for global morbidity and mortality. 1 Even low levels across the United States pose significant public health risks 3 ;however, no proven personal strategy exists to protect at-risk individuals. 4 We demonstrate herein that 2 relatively inexpensive (<US $70), commercially available portable air filtration systems can significantly decrease SBP and 24-hour mean personal PM 2.5 exposure in elderly adults in a typical urban US location (Detroit). There was also a concomitant reduction in DBP; however, this change did not reach statistical signifi-
cance. We further demonstrate that health benefits may appear more rapidly than previously known, 12,16 with BP reductions manifesting within 3 days. Notably, 24-hour mean reductions in personal PM 2.5 exposures occurred despite air filtration systems being fixed to indoor in-residence locations. The effectiveness of this intervention on personal exposures is important because in real-world scenarios, people spend a variable portion of time outside of their residence. and single measurement of follow-up BP may have contributed to their null findings. Nevertheless, together with our new findings, the overall body of evidence highlights the need for further large-scale investigations to fully understand the potential health benefits of air filtration systems.
Biological Mechanisms
Short-term increases in ambient PM 2.5 concentrations promote elevated arterial BP in areas with poor or good air quality. [22] [23] [24] [25] [26] Autonomic imbalance favoring sympathetic activation and vascular dysfunction have been implicated.
2,24,25
Our study could not elucidate the precise mechanism because HRV metrics and arterial function variables were not consistently improved with filtration. This finding may be owing to inadequate power to evaluate secondary end points or research technique shortcomings or because other pathways may be responsible. Nonetheless, our results support a trend toward improved central aortic hemodynamics and arterial compliance with parallel decreases in brachial BP. In follow-up analyses, we will evaluate via metabolomic profiling whether stress hormones (eg, activation of the hypothalamic-pituitaryadrenal axis) or other hemodynamically active mediators were mechanistically involved. 31 We will also investigate whether microvascular tone, assessed by retinal arterial photography, played a mediating role.
Clinical Implications
For this study, BP was only monitored during a 3-day period of air filtration. However, the observed 3.2-mm Hg reduction in SBP could possibly be sustained for more prolonged interventions. Even such modestly lower BP levels, if maintained for the long term (eg, months to years), could result in an approximate 16% decrease in composite CV events based on epidemiologic calculations. 21 Given the size of the population affected by PM 2.5 exposure, 1 widespread use of economical exposurereduction solutions could potentially deliver substantial improvements in global public health. 4 We recognize this possibility is only speculation, and we aim to launch a follow-up study specifically to evaluate the efficacy and health benefits of longerterm interventions. Our results also showed that participants with obesity may exhibit greater decreases in BP from air filtration. This finding is consistent with that of a recent review in which 11 of 14 panel studies showed stronger associations between PM 2.5 exposure and acute changes in physiological measures of CV health among obese participants, including BP. 32 Because the prevalence of obesity has more than doubled since 1980, improved understanding of the interactions among air pollution, obesity, CV health, and intervention tools will be required to tackle this important public health issue. A recent study of the Medicare population 3 demonstrated that the adverse effects of PM 2.5 exposure are more pronounced among self-identified racial minorities and people with low income. Seniors in urban low-income housing are particularly vulnerable to air pollution, and an economical and easily implemented intervention is needed to reduce their PM exposure. This group is understudied; in 2015, almost 4.2 million seniors lived below the poverty level and another 2.4 million were classified as near poor. 19 To our knowledge, this study is the first to focus on low-income housing facilities in an urban US environment and on personal PM 2.5 exposures.
Limitations
Although the slightly more expensive HE system was more effective in reducing personal exposures, this intervention did not clearly yield superior CV health outcomes, likely because the study was a priori powered to detect a difference in SBP while using any air filtration (HE and LE pooled together) vs sham filtration. This power may have therefore been inadequate to detect statistically significant changes in secondary CV outcomes. As such, the differences shown in Figure 3 represent secondary (hypothesis-generating) end points only, and a larger follow-up trial is needed to determine whether the small (statistically insignificant) differential BP response unexpectedly favoring LE over HE filtration was a result of chance alone, as we suspect. Although this study showed that interventions as short as 24 hours can reduce BP, previous studies 10 suggest that a longer intervention (eg, 9 days) might have demonstrated more robust changes and detectable improvements in our secondary CV outcomes. A preliminary study in Taiwan  31 conducted for 1 year suggests that this may indeed be the case. Longerterm studies of months to years in duration are ultimately required to determine whether health benefits of air filtration persist and could thereby potentially translate into reductions in overt CV events (eg, myocardial infarctions). The study size and design were inadequate for assessing effect modification by multiple factors. Our objective was to model a real-world scenario as much as possible; thus, we did not exclude participants based on the presence of many comorbidities, including hypertension or use of specific antihypertensive medications. The heterogeneous nature of the participants may have also led to variability in responses owing to differences in underlying disease states and medications. Furthermore, although the participants were nonsmokers and the residential building was a nonsmoking building, we did not assess effects of secondhand smoke. In future analyses, we plan to assess PM 2.5 components and their sources (eg, smoking) related to changes in CV outcomes.
Whether such in-home interventions would be less effective among more free-living adults, such as those who spend more time outside their residence, also remains unknown. Considering these limitations, larger trials are required to determine optimal populations to target and the comparative effectiveness among various strategies (eg, face masks) for intervention.
Finally, the primary study end point was brachial BP. Although SBP significantly decreased, the reduction in DBP after any filtration did not reach statistical significance, most likely because we specifically powered the study based on changes in SBP and it may have therefore been underpowered to detect a decrease in DBP. Our prior studies in Detroit had suggested that ambient PM 2.5 may have a more consistent association with SBP compared with DBP. 22, 23 However, recent studies have found that ambient PM 2.5 can increase SBP and DBP. 24 In this study, DBP was also significantly decreased by LE filtration. These findings suggest that future trials with appropriate power are warranted to determine whether air filtration indeed lowers DBP and not just SBP. Regardless, the fact that SBP alone was reduced in this study is still of clinical relevance because SBP is well established as a stronger and more important determinant of CV risk in elderly people than DBP.
33
Conclusions
In this trial, use of indoor portable air filtration for 3 days led to significant reductions in SBP in elderly adults. Our findings suggest that this relatively inexpensive and practical approach may be an effective tool for reducing PM 2.5 -related health effects. Future studies are required to better understand how to optimally deploy this personal-level intervention in real-world settings, how it performs among different populations (eg, patients with established cardiovascular diseases), and its efficacy over longer time frames (eg, >9 days). 
Research Protocol
On Monday during study week 1, the study team placed blinded randomized portable air filter systems (HE-filtration, LE-filtration or no filter) in each participant's residence. The participants also wore small, battery-powered air monitors starting at 8:00 AM, and continued to carry the monitors until Thursday morning at 8:00 AM. Each subject had daily CV outcome testing performed in a fasting condition (>8 hrs) at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement (Tues-Thurs). Questionnaires were used to collect information on factors influencing between-subject variance and factors constant over the study period. Subjects underwent each 3-day long intervention and outcome measurement block on 3 separate occasions with a washout period of at least one week between blocks (no presumed carry-over effect between blocks).
Intervention
Daily samples were collected in each subject's home throughout each 3-day filtration period, during which time either no filtration, low-cost, LE (Holmes HAPF30 filter) or more expensive, HE (Holmes HAPF300D filter) recirculating filtration was used. For the "w/o filter" condition, the air cleaner was operated normally without any filter element (i.e., sham filtration) so that filtration status was unknown to the subjects. All air cleaners exhibited similar noise (average of 46 decibels at 6 feet with no significant difference between scenarios) and identical outward appearance regardless of filtration status. The sequence of the filtration scenarios for each subject was randomized. Air flow rates for HE and LE filtration were measured so that turnover rates can be calculated, enabling our results to be applied to differently-sized dwellings.
CV Outcome Measurements
Our prior studies have shown many of the selected CV health outcomes to be associated with PM 2.5 concentrations. The chosen CV assessment methodologies utilize equipment that can be readily transported and employed at the senior residential facility itself, and pose little or no risk to subjects. In addition, each outcome is a dynamic physiological parameter reflecting an important homeostatic CV mechanism well-known to respond within hours-to-days to an intervention or an insult (e.g., PM exposure). Finally, each outcome has been shown to be independently associated with or predict hard CV outcomes -thus they each represent important indicators of critical biological changes plausibly conveying an increase in risk for overt CV events. The outcomes provided complementary and differing biological information on CV health status, and employing them together thereby provided a comprehensive assessment of the CV impact of PM exposure and its reduction.
A single room was designated for all patient testing. Each examination was performed in this same room with constant internal lighting conditions and temperature held at 70-72 ºF. A portable subject examination bed was used for all patients to lie supine resting as required prior to and during examination. All testing was performed in a unified manner in this room at the same time each morning, with all outcomes being measured in a fasting state (>8 hrs). Subjects took any morning medications after performing these measurements.
Completing all measurements took between 30-45 minutes, and they were performed each morning in the following order. Subjects rested seated for 5 minutes. Brachial BP was determined using the dominant arm resting at heart level per guidelines (Pickering et al., 2005) . Afterwards, subjects rested seated for an additional 5 minutes and then had their resting arteriole tone measured by retinal photography. Next, subjects lay resting supine on a bed for 10 minutes and thereafter had the sphygmoCor outcomes performed. Repeat testing has been definitively demonstrated not to alter subsequent testing results (Harris 2006) . We have performed repeat testing numerous times (on the same day 1-2 hours apart as well as on five subsequent mornings) and have observed no same room with constant internal lighting conditions and temperature held at approx. 72 °F.
effect of the order of testing on the outcomes for brachial FMD, endoPAT, or other testing results (Brook et al., 2011) .
Brachial blood pressure: BP is a well-established predictor of the risk for CV events, and was measured according to guidelines (Pickering et al., 2005) using the validated BPTru device (http://www.bptru.com/html-pages/index.html). The BPTru is an automated oscillometric BP monitor that measures brachial BP without medical personnel present. This device was placed in a location where subjects had their BP measured while resting seated alone in a quiet room. The average of the last 5 of 6 automated BP measurements was recorded. This BP outcome is free of the white-coat response and is a superior indicator of 24-hour ambulatory BP and target organ status (Myers et al., 2011; Myers and Godwin 2012) .
Aortic compliance and central aortic hemodynamics:
The SphygmoCor device was used to measure these outcomes (http://www.atcormedical.com); the protocols are described in detail elsewhere (Pickering et al., 2005; Myers et al., 2011) . Central aortic BP differs from arm levels depending on a variety of clinical parameters and is established to be a superior predictor of heart, brain, and kidney target organ status and CV events. The device also measures aortic augmentation index (AIx) (an index of arterial pressure wave reflection) and coronary perfusion index. These parameters are provided by pulse wave analyses of the radial artery using applanation tonometry and a mathematical generalized transfer function approved by the FDA. The device also provides the gold-standard measurement of arterial stiffness by measurement of pulse wave velocity (PWV) via carotid and femoral applanation tonometry. These results have independent CV prognostic abilities incremental to standard arm BP and are better measures of the hemodynamics faced by the heart, brain, and kidneys and are thus superior predictors of target organ damage/status (Laurent et al., 2006; Agabiti-Rosei et al., 2007; Nelson et al., 2010) . Both AIx (central aortic hemodynamics) (Vlachopoulos et al., 2010) and PWV have been independently linked to adverse CV outcomes. We have extensive expertise with these techniques and have employed the SphygmoCor device in numerous past and ongoing studies.
Exposure Assessment
Outdoor air pollution sampling and measurement: Ambient PM 2.5 samples were collected daily on Teflon filters using a dichotomous sequential air sampler (Partisol-Plus Model 2025, Rupprecht and Patashnick, Inc., Albany, NY) for subsequent gravimetric analysis of PM 2.5 . This sampler maintained sampling flow rates of 16.7 L/min using integrated volumetric flow controllers, and also measured, averaged and stored ambient temperature, atmospheric pressure and relative humidity. The outdoor PM sampling equipment was positioned on the roof of a three-story building ~80 m NW of the residence due to power requirements and safety issues.
Indoor air pollution sampling: Indoor sampling of PM 2.5 was done concurrently with the daily outdoor sampling. Indoor air pollution sampling equipment was positioned at the furthest point in the room diagonally away from the air filtration unit. Indoor PM 2.5 samples were collected onto Teflon filter media using Teflon-coated aluminum cyclone sample inlets at a nominal flow rate of 16.7 L/min as determined via calibrated rotameters (Matheson Inc., Montgomeryville, PA). The indoor sampling used pump systems designed and fabricated at the University of Michigan Air Quality Laboratory for previous studies (Keeler et al., 2002) . These pump systems used acoustically-insulated wood cases designed for operation in home environments, thus minimizing pump noise during sampling periods.
Personal air sampling and measurement: Each subject wore a battery-powered active air monitor -a personal particulate monitor (Thermo Scientific pDR-1500) -designed to continuously measure PM 2.5 concentrations, providing data logging and a continuous readout. The monitor only weighed a total of 2 lb, minimizing physical burden on subjects. The personal particulate monitors were carried with the subjects throughout each day both indoors and outdoors. While the subjects slept, the monitors were placed on a nearby nightstand or equivalent. The pDR-1500 also collected sampled particles onto 37-mm Teflon filters for subsequent gravimetric analysis. Continuous data collected by these personal monitors (compared to 24-hr integrated mass values) facilitated assessment of short-term pollutant episodes and determination of contributions from outdoor local sources and indoor sources which can impact the subject on very short time frames.
Sample analysis: Sample handling, processing, and analysis took place in Class 100 and Class 1000 ultraclean rooms at the University of Michigan Air Quality Laboratory and Michigan State University Exposure Science Laboratory. Gravimetric determinations were made using a microbalance (MT-5, Mettler Toledo, Columbus OH) in a temperature/humidity-controlled environment as described in the Federal Reference Method (EPA 1997).
Statistical Analyses
We examined the distributions of outcomes and exposures under each intervention (filtration scenario), as well as individual and mean profiles over time. Graphical approaches such as boxplots and scatterplots with linear or non-linear (e.g., loess) methods were used, allowing identification of outliers, linearity, and correlation of measurements within person and across time. If outcome data did not appear normally distributed, transformations were employed. Because each subject's outcomes and exposures were measured at more than one point in time, our analyses were based on linear mixed effects models (Diggle et al., 1994; Verbeke and Molenberghs 2000; Fitzmaurice et al., 2004) . Our a priori time frame of interest after each intervention is 24-hours, although we also investigated models separately for 48-and 72-hours to explore different lag periods. Selection of important covariates and confounders was based on prior knowledge and bivariate associations assessed during exploratory data analyses. We expected no carryover since interventions were spaced at least one week apart. Tests to compare filtration scenarios were based on Wald and chi-squared tests based on maximum likelihood or restricted maximum likelihood methods. Alternative covariance structures (other than compound symmetry) were explored and model fit was examined using the Akaike Information Criteria (Burnham and Anderson 2004) .
We tested whether LE and HE filters resulted in statistically better CV outcomes and lower PM 2.5 levels than no filtration using models of the following form: CVit = (bo + bi) + (11*LEit + 12*HEit ) + 2*CONFOUNDERit + it where CVit is the continuous CV health outcome (basal microvascular tone, brachial BP, central aortic BP, PWV, inflammatory biomarkers) in individual i at time t; LE it and HE it are indicator variables indicating the filtration scenario for individual i at time t (with unfiltered air as the referent category); CONFOUNDER it is a vector of potential confounders or covariates (e.g., age, gender, or time-varying covariates such as daily medication use); bo is the overall intercept; bi is the separate random intercept for individual i which accounts for correlation within repeated measures from an individual and is assumed to be an independently distributed random variable with mean zero and variance 2 b ; 11 and 12 are the overall effects of LE vs unfiltered air and HE vs unfiltered air, respectively; 2 is the overall effect of confounders or covariates; it is the random error (e.g., measurement error) of the t th observation on the i th individual and is assumed to be an independently distributed random variable with mean zero and variance
.
Sample Size and Power Considerations: The sample size for this study was based on a combination of logistical considerations and power required to detect important differences in key CV parameters (RHI and systolic BP) and PM 2.5 levels in the context of a randomized crossover design with repeated measures. Power was calculated for 40 individuals with 3 repeat samples under each intervention (no, LE, and HE filtration) using a 6-sequence, 3-period, 3-treatment crossover design. Brook et al (2011) provide estimates of the effect expected with significant (10 µg/m 3 ) increase in personal-level PM 2.5 exposure: 0.17 difference in RHI and 1.4 mmHg elevation in systolic BP. Previous studies by these investigators support assumed intersubject variability of 4.0 µg/m 3 , 0.4, and 6.2 mmHg for PM 2.5 , RHI, and systolic BP, respectively. Intrasubject variability was assumed to be the same for all samples at 9.2 µg/m 3 , 0.4, and 3.3 mmHg. Given that measurements were made more closely in time within interventions than across interventions, one might anticipate higher correlation for those samples; however, we lacked data to estimate that correlation structure so our power calculations may be slightly anticonservative. For this reason we sized our study to achieve 90% power using a two-sided Type I error of 5% to allow for potentially alternate correlation structure and multiplicity. Results from past research (Brook et al., 2009) showing statistically significant findings for endothelial function further support our proposed sample size. Ultimately, we estimated 90% power to detect a 3.5 µg/m 3 difference in PM 2.5 , a 1.4 mmHg difference in systolic BP, and a 0.17 difference in RHI with filtration as compared to unfiltered air (Table 1 ) based on F tests in the crossover setting (Jones and Kenward 1989 
